What is Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (002317.SZ) StockRank?

MoatMap's StockRank for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) is 60/100, with a Hold signal. This is a composite score combining Quality (66), Value (20), and Momentum (62) factor ranks across MoatMap's 19,000+ stock universe.

Does Guangdong Zhongsheng Pharmaceutical Co., Ltd. have an economic moat?

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Guangdong Zhongsheng Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) is Hold, based on a StockRank of 60/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Guangdong Zhongsheng Pharmaceutical Co., Ltd. in?

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002317.SZ

HOLDREMOVE

Guangdong Zhongsheng Pharmaceutical Co., Ltd. · Healthcare · China · $3.0B · Avg Vol: $165M/d

StockRank

P/E (TTM)

63.7x

ROE

6.8%

D/E

0.1x

Dividend %

0.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Domestic Chinese pharmaceutical player facing regulatory headwinds, centralized procurement price cuts, and lack of global scale.

COMPANY DESCRIPTION

Guangdong Zhongsheng Pharmaceutical Co., Ltd. develops and manufactures pharmaceutical products, with a dominant position in Traditional Chinese Medicine (TCM) for ophthalmic and cardiovascular therapies. The company's competitive moat is supported by proprietary TCM formulas, such as Xuesaitong, and an expanding pipeline of innovative small-molecule chemical drugs targeting NASH and viral infections. It operates as a specialized pharmaceutical player bridging traditional therapies and modern drug discovery.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	396M	386M	365M	373M	-1.9%
EPS	0.06	0.05	-0.05	0.05	-6.2%
Shares	814M	853M	852M	850M	+4.4%
Debt	133M	107M	122M	48M	-28.8%
Equity	547M	644M	579M	600M	3.1%
Op CF	9M	28M	50M	45M	69.1%
Inv CF	-78M	-110M	57M	7M	—
Fin CF	53M	124M	-83M	-109M	—

PRICE (1M)+17.3%

SMA 50SMA 200

$3.23

RSI (14)

37.4

52W High

$4.10

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

6.8%62.8

ROE

6.8%62.3

GP/Assets

27.6%61.0

Op. Margin

18.7%80.5

FCF/Assets

-0.6%48.8

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.07x71.0

Current Ratio

4.13x64.6

Value

P/E (TTM)

63.7x15.6

EV/EBITDA

42.7x7.8

P/FCF

—N/A

P/B

4.6x26.7

P/S

7.5x30.9

Div Yield

0.9%23.9

Momentum

52W High %

79%72.5

RS 6M

-12%66.3

SMA 50/200

1.03x67.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—35.6

Q Growth

21%63.4

FUNDAMENTALS

Market Cap

$3.0B

P/E (Forward)

51.8x

Gross Margin

56.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002317.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.(you)	$3.0B	60	HOLD
300142.SZ	Walvax Biotechnology Co., Ltd.	$3.0B	67	BUY
000623.SZ	Jilin Aodong Pharmaceutical Group Co., Ltd.	$3.0B	69	BUY
603858.SS	Shandong Buchang Pharmaceuticals Co., Ltd.	$2.3B	66	BUY
300199.SZ	Hybio Pharmaceutical Co., Ltd.	$3.0B	48	HOLD
002399.SZ	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$2.2B	67	BUY
603707.SS	Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.	$1.9B	65	BUY
603456.SS	Zhejiang Jiuzhou Pharmaceutical Co., Ltd	$1.7B	62	HOLD
301246.SZ	Hubei Hongyuan Pharmaceutical Technology Co., Ltd.	$1.9B	66	BUY
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.	$1.7B	57	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) — Stock Score Summary

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) has a MoatMap StockRank of 60/100 based on Quality (66/100), Value (20/100), and Momentum (62/100) factor scores. The current signal is HOLD. Domestic Chinese pharmaceutical player facing regulatory headwinds, centralized procurement price cuts, and lack of global scale.

Key Financial Metrics

Price	$3.23
Market Cap	$3.0B
P/E (TTM)	63.66
P/E (Forward)	51.81
Price/Book	4.55
Return on Equity	6.8%
Return on Invested Capital	6.8%
Debt/Equity	6.95
Gross Margin	56.1%
Operating Margin	18.7%
Revenue Growth	-1.6%
Dividend Yield	0.9%
Free Cash Flow	$-647K

Guangdong Zhongsheng Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s (002317.SZ) StockRank?: MoatMap’s StockRank for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) is 60/100, with a Hold signal. It is a composite of Quality (66), Value (20), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Guangdong Zhongsheng Pharmaceutical Co., Ltd. have an economic moat?: Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guangdong Zhongsheng Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) is Hold, based on a StockRank of 60/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guangdong Zhongsheng Pharmaceutical Co., Ltd. in?: Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).